Granulocyte Macrophage-Colony Stimulating Factor and Ipilimumab as Therapy in Melanoma
Clinical trial NCT01363206 · COMPLETED
Trial details
- NCT number
- NCT01363206
- Sponsor
- Lynn E. Spitler, MD
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2011-05-01
- Primary completion
- 2014-05-01
- Enrollment
- 29
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.